CCEL Cryo-Cell International Inc: Total Debt to Equity Ratio

Cryo-Cell - graphic logo of issuer CCEL

This daily price chart illustrates the debt-to-equity ratio of Cryo-Cell International (CCEL), which stands at 0.00. Cryo-Cell International (CCEL) holds the status of the oldest American biomaterials depository with an impeccable reputation. The business relies on a closed-loop cryogenic service cycle that generates high customer loyalty. However, growth is complicated by demographic decline and the potential transformation of medical protocols regarding the application of cellular technologies.

CCEL: Cryo-Cell International Inc Debt to Capital 07/04/2022 - 10/30/2026
Finished products of Cryo-Cell International, Inc.

The steady development of regenerative medicine technologies and R&D in cell therapy require significant funding, making debt load control critically important for Cryo-Cell International (CCEL). Analyzing the company's debt-to-equity ratio allows for an assessment of the proportion of borrowed funds within the balance sheet structure, determining the business's degree of financial autonomy and the risk of the asset becoming a value trap in the event of excessive leverage.